Cibus, Inc. (NASDAQ:CBUS – Get Free Report) was the recipient of a significant drop in short interest in the month of January. As of January 31st, there was short interest totalling 2,110,000 shares, a drop of 8.7% from the January 15th total of 2,310,000 shares. Approximately 10.2% of the shares of the company are short sold. Based on an average daily volume of 166,400 shares, the days-to-cover ratio is currently 12.7 days.
Institutional Investors Weigh In On Cibus
A number of hedge funds and other institutional investors have recently bought and sold shares of CBUS. SG Americas Securities LLC purchased a new position in shares of Cibus in the third quarter valued at $33,000. Charles Schwab Investment Management Inc. increased its position in shares of Cibus by 14.6% in the third quarter. Charles Schwab Investment Management Inc. now owns 49,285 shares of the company’s stock valued at $161,000 after buying an additional 6,276 shares in the last quarter. FMR LLC increased its position in shares of Cibus by 16.9% in the third quarter. FMR LLC now owns 3,913,279 shares of the company’s stock valued at $12,757,000 after buying an additional 566,328 shares in the last quarter. Swan Global Investments LLC purchased a new position in shares of Cibus in the third quarter valued at $115,000. Finally, HighTower Advisors LLC increased its position in Cibus by 20.6% during the 3rd quarter. HighTower Advisors LLC now owns 16,125 shares of the company’s stock worth $52,000 after purchasing an additional 2,750 shares in the last quarter. Institutional investors and hedge funds own 33.81% of the company’s stock.
Analyst Ratings Changes
CBUS has been the subject of several recent research reports. Canaccord Genuity Group decreased their price target on Cibus from $20.00 to $18.00 and set a “buy” rating for the company in a report on Wednesday, January 22nd. HC Wainwright reissued a “buy” rating and issued a $25.00 target price on shares of Cibus in a report on Monday, November 11th.
Cibus Stock Performance
Cibus stock opened at $2.61 on Wednesday. Cibus has a one year low of $2.16 and a one year high of $23.18. The business has a fifty day moving average of $2.77 and a two-hundred day moving average of $4.20. The company has a market cap of $69.06 million, a P/E ratio of -0.12 and a beta of 1.82.
About Cibus
Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.
Recommended Stories
- Five stocks we like better than Cibus
- P/E Ratio Calculation: How to Assess Stocks
- Hims & Hers Earnings Could Be a Game Changer—What to Do Now
- Manufacturing Stocks Investing
- DeepSeek IPO Remains Far Off—Investors Eye 4 Chinese AI Stocks
- How to Invest in Blue Chip Stocks
- Mortgage Market Bottom? Why Rocket Companies Could Be a Buy
Receive News & Ratings for Cibus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cibus and related companies with MarketBeat.com's FREE daily email newsletter.